2-[[4-[[3-(benzenesulfonylmethyl)-5-methyl-phenoxy]methyl]phenyl]methyl-methyl-amino]ethanol

ID: ALA5171997

Chembl Id: CHEMBL5171997

PubChem CID: 168270654

Max Phase: Preclinical

Molecular Formula: C25H29NO4S

Molecular Weight: 439.58

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN(C)CCO)cc2)c1

Standard InChI:  InChI=1S/C25H29NO4S/c1-20-14-23(19-31(28,29)25-6-4-3-5-7-25)16-24(15-20)30-18-22-10-8-21(9-11-22)17-26(2)12-13-27/h3-11,14-16,27H,12-13,17-19H2,1-2H3

Standard InChI Key:  FFXMVJCNFRPFAX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5171997

    ---

Associated Targets(Human)

SPHK2 Tchem Sphingosine kinase 2 (1579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.58Molecular Weight (Monoisotopic): 439.1817AlogP: 3.97#Rotatable Bonds: 10
Polar Surface Area: 66.84Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.56CX LogP: 4.02CX LogD: 2.84
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.52Np Likeness Score: -1.35

References

1. Zhang S, Chen X, Wu C, Xu H, Xie X, Feng M, Hu S, Bai H, Gao F, Tong L, Ding J, Liu H, Xie Z, Wang J..  (2022)  Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer.,  65  (11.0): [PMID:35439002] [10.1021/acs.jmedchem.2c00040]

Source